« Back to Article
Print this article

Cipla HIV drug gets USFDA nod

June 26, 2006 12:18 IST

Cipla has got tentative approval from the United States Food & Drug Administration for its abbreviated new drug application for anti-HIV/AIDS drug Slamivudine.

According to information available on the USFDA website, the tentative approval is for the oral solution of strength 10mg per ml.

The drug is in a class of medications called nucleoside reverse transcriptase inhibitors. It works by stopping the spread of the HIV and hepatitis B viruses.

Do you want to discuss stock tips? Do you know a hot one? Join the Stock Market Investments Discussion Group

© Copyright 2025 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.